Summary
E.I. du Pont de Nemours and Company (DuPont) presents its 2011 Annual Report, highlighting robust net sales growth of 20% to $38.0 billion, driven by a 17% increase in local selling prices and contributions from the significant $6.4 billion acquisition of Danisco A/S. Despite strong performance across most segments, particularly Agriculture and Performance Chemicals, the company's net income attributable to DuPont saw a 15% increase to $3.47 billion, or $3.68 per diluted share. This growth was partially tempered by an increase in raw material and energy costs, as well as specific charges related to the Danisco integration and the Imprelis herbicide claims. DuPont's strategic focus remains on applying science to address global challenges in food, energy, and safety. The company continues to invest heavily in research and development, with R&D expenses rising to $1.96 billion, demonstrating a commitment to innovation. Geographic diversification is evident, with international sales comprising 65% of total revenue, and developing markets showing a strong 27% growth in 2011. The company maintains a strong balance sheet and continues its practice of returning excess cash to shareholders through dividends and share repurchases, while also projecting continued sales and earnings growth for 2012.
Financial Highlights
57 data points| Revenue | $33.68B |
| Cost of Revenue | $21.26B |
| Gross Profit | $12.42B |
| R&D Expenses | $1.96B |
| SG&A Expenses | $3.31B |
| Operating Expenses | $30.54B |
| Operating Income | $5.88B |
| Interest Expense | $447.00M |
| Net Income | $3.60B |
| EPS (Basic) | $3.82 |
| EPS (Diluted) | $3.77 |
| Shares Outstanding (Basic) | 928.42M |
| Shares Outstanding (Diluted) | 941.03M |
Key Highlights
- 1Net sales increased by 20% to $37.96 billion, driven by higher local selling prices and the acquisition of Danisco A/S.
- 2Acquisition of Danisco A/S for $6.4 billion was a major event in 2011, contributing $1.7 billion in net sales.
- 3Net income attributable to DuPont grew 15% to $3.47 billion, or $3.68 per diluted share.
- 4The Agriculture segment showed strong performance with a 17% increase in sales to $9.17 billion, driven by both seed and crop protection products.
- 5Research and Development (R&D) expenses increased by $305 million to $1.96 billion, reflecting continued investment in innovation.
- 6International sales represented 65% of total revenue, with developing markets showing significant growth of 27%.
- 7The company maintained a consistent dividend payment history and continued share repurchases.